DefiniGEN appoints Dr Chris Kirton as Chief Executive Officer 21 Jan Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous Eagle Genomics Selected for Catalonia-Based Initiative to Support Expansion into Spanish-Speaking Markets Next Next Arecor commences US Phase I clinical trial of AT247 ultra-rapid insulin in combination with an insulin pump
DefiniGEN appoints Dr Chris Kirton as Chief Executive Officer 21 Jan Written by Alexandra Collingbourne Alexandra Collingbourne
